These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Toxic effects of L-DOPA on mesencephalic cell cultures: protection with antioxidants. Pardo B; Mena MA; Casarejos MJ; Paíno CL; De Yébenes JG Brain Res; 1995 Jun; 682(1-2):133-43. PubMed ID: 7552304 [TBL] [Abstract][Full Text] [Related]
3. Comparison of neurotoxicity following repeated administration of l-dopa, d-dopa and dopamine to embryonic mesencephalic dopamine neurons in cultures derived from Fisher 344 and Sprague-Dawley donors. Alexander T; Sortwell CE; Sladek CD; Roth RH; Steece-Collier K Cell Transplant; 1997; 6(3):309-15. PubMed ID: 9171163 [TBL] [Abstract][Full Text] [Related]
4. Catechol-O-methyltransferase inhibition protects against 3,4-dihydroxyphenylalanine (DOPA) toxicity in primary mesencephalic cultures: new insights into levodopa toxicity. Blessing H; Bareiss M; Zettlmeisl H; Schwarz J; Storch A Neurochem Int; 2003 Jan; 42(2):139-51. PubMed ID: 12421594 [TBL] [Abstract][Full Text] [Related]
6. Methylphenylpyridium ion (MPP+) enhances glutamate-induced cytotoxicity against dopaminergic neurons in cultured rat mesencephalon. Sawada H; Shimohama S; Tamura Y; Kawamura T; Akaike A; Kimura J J Neurosci Res; 1996 Jan; 43(1):55-62. PubMed ID: 8838574 [TBL] [Abstract][Full Text] [Related]
7. NMDA receptor involvement in toxicity to dopamine neurons in vitro caused by the succinate dehydrogenase inhibitor 3-nitropropionic acid. Zeevalk GD; Derr-Yellin E; Nicklas WJ J Neurochem; 1995 Jan; 64(1):455-8. PubMed ID: 7798946 [TBL] [Abstract][Full Text] [Related]
8. Glia conditioned medium protects fetal rat midbrain neurones in culture from L-DOPA toxicity. Mena MA; Casarejos MJ; Carazo A; Paino CL; García de Yébenes J Neuroreport; 1996 Jan; 7(2):441-5. PubMed ID: 8730801 [TBL] [Abstract][Full Text] [Related]
9. Differential neurotoxicity induced by L-DOPA and dopamine in cultured striatal neurons. Cheng N; Maeda T; Kume T; Kaneko S; Kochiyama H; Akaike A; Goshima Y; Misu Y Brain Res; 1996 Dec; 743(1-2):278-83. PubMed ID: 9017256 [TBL] [Abstract][Full Text] [Related]
10. Toxic and protective effects of L-dopa on mesencephalic cell cultures. Mytilineou C; Han SK; Cohen G J Neurochem; 1993 Oct; 61(4):1470-8. PubMed ID: 8376999 [TBL] [Abstract][Full Text] [Related]
12. A selective toxicity toward cultured mesencephalic dopaminergic neurons is induced by the synergistic effects of energetic metabolism impairment and NMDA receptor activation. Marey-Semper I; Gelman M; Lévi-Strauss M J Neurosci; 1995 Sep; 15(9):5912-8. PubMed ID: 7666176 [TBL] [Abstract][Full Text] [Related]
13. Effects of L-DOPA on nigral dopamine neurons and local field potential: comparison with apomorphine and muscimol. Xu D; Karain B; Brantley E; Shi WX J Pharmacol Exp Ther; 2011 May; 337(2):533-9. PubMed ID: 21330359 [TBL] [Abstract][Full Text] [Related]
14. NMDA receptor antagonism potentiates the L-DOPA-induced extracellular dopamine release in the subthalamic nucleus of hemi-parkinson rats. El Arfani A; Bentea E; Aourz N; Ampe B; De Deurwaerdère P; Van Eeckhaut A; Massie A; Sarre S; Smolders I; Michotte Y Neuropharmacology; 2014 Oct; 85():198-205. PubMed ID: 24863042 [TBL] [Abstract][Full Text] [Related]
15. The mitochondrial complex I inhibitor annonacin is toxic to mesencephalic dopaminergic neurons by impairment of energy metabolism. Lannuzel A; Michel PP; Höglinger GU; Champy P; Jousset A; Medja F; Lombès A; Darios F; Gleye C; Laurens A; Hocquemiller R; Hirsch EC; Ruberg M Neuroscience; 2003; 121(2):287-96. PubMed ID: 14521988 [TBL] [Abstract][Full Text] [Related]
16. Co-culture with the striatum attenuates N-methyl-D-aspartate cytotoxicity in dopaminergic neurons of rat mesencephalic slice cultures. Maeda T; Ibi M; Shimazu S; Akaike A Jpn J Pharmacol; 1998 Jun; 77(2):161-7. PubMed ID: 9681573 [TBL] [Abstract][Full Text] [Related]
17. Effects of wild-type and mutated copper/zinc superoxide dismutase on neuronal survival and L-DOPA-induced toxicity in postnatal midbrain culture. Mena MA; Khan U; Togasaki DM; Sulzer D; Epstein CJ; Przedborski S J Neurochem; 1997 Jul; 69(1):21-33. PubMed ID: 9202290 [TBL] [Abstract][Full Text] [Related]
18. Dopamine inhibition: enhancement of GABA activity and potassium channel activation in hypothalamic and arcuate nucleus neurons. Belousov AB; van den Pol AN J Neurophysiol; 1997 Aug; 78(2):674-88. PubMed ID: 9307104 [TBL] [Abstract][Full Text] [Related]